drugset / Trial / NCT06245707
the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study intends to apply prospective, open, single-center, randomized controlled study to evaluate the cognitive status of patients with Idiopathic membranous nephropathy and the influence of different treatment schemes on the cognitive status of patients with Idiopathic membranous nephropathy, and explore the possible pathophysiological mechanism by using brain magnetic resonance imaging technology.
Timeline
- Start
- 2023-10-01
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 2 mg/kg | Oral |
| Subject | Methylprednisone | Unknown | 500 mg | Intravenous |
| Subject | Prednisone | Other / unclassified | 0.5 mg/kg | — |
| Subject | Rituximab | Monoclonal antibody | — | — |